Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļFMS
āļāļ·āđāļāļāļĢāļīāļĐāļąāļFresenius Medical Care AG
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 02, 1996
āļāļĩāļāļĩāđāļCordola (Craig)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ111513
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļOct 02
āļāļĩāđāļāļĒāļđāđElse-Kroener-Strasse 1
āđāļĄāļ·āļāļBAD HOMBURG VOR DER HOHE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻGermany
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ61352
āđāļāļĢāļĻāļąāļāļāđ4961726090
āđāļ§āđāļāđāļāļāđhttps://www.freseniusmedicalcare.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļFMS
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 02, 1996
āļāļĩāļāļĩāđāļCordola (Craig)
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
ActivePassive International Equity ETF
Avantis Responsible International Equity ETF
Avantis International Equity ETF
Pacer Developed Markets International Cash Cws 100
Unusual Whales Subversive Democratic Trading ETF
DFA Dimensional International Core Equity 2 ETF
SGI Enhanced Global Income ETF
Unusual Whales Subversive Republican Trading ETF
The Opal International Dividend Income ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Cultivar ETF
āļŠāļąāļāļŠāđāļ§āļ1.01%
ActivePassive International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.08%
Avantis Responsible International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.06%
Avantis International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.01%
Pacer Developed Markets International Cash Cws 100
Unusual Whales Subversive Democratic Trading ETF
DFA Dimensional International Core Equity 2 ETF
SGI Enhanced Global Income ETF
Unusual Whales Subversive Republican Trading ETF
The Opal International Dividend Income ETF
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
1.59B
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020